Y10S 530/868
Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Official title: involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Y10S530/868 (Involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance) appears on 379 US grants and 152 published applications in this corpus.
Search patents in Y10S- Granted patents
- 379
- Published applications
- 152
- Assignees
- 205
- Inventors
- 546
- Latest grant
- 11 Sep 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 1 | 0 |
| 1982 | 9 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 4 | 0 |
| 1987 | 11 | 0 |
| 1988 | 6 | 0 |
| 1989 | 5 | 0 |
| 1990 | 11 | 0 |
| 1991 | 1 | 0 |
| 1992 | 8 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 12 | 0 |
| 1997 | 19 | 0 |
| 1998 | 30 | 0 |
| 1999 | 26 | 0 |
| 2000 | 31 | 0 |
| 2001 | 17 | 7 |
| 2002 | 12 | 21 |
| 2003 | 18 | 21 |
| 2004 | 7 | 10 |
| 2005 | 8 | 10 |
| 2006 | 14 | 13 |
| 2007 | 14 | 10 |
| 2008 | 10 | 8 |
| 2009 | 14 | 11 |
| 2010 | 5 | 9 |
| 2011 | 11 | 4 |
| 2012 | 9 | 13 |
| 2013 | 6 | 6 |
| 2014 | 6 | 3 |
| 2015 | 4 | 3 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for altering the binding specificity of plasma proteins by oxidation11 Sep 2018US 10,072,068 B2Redox-Reactive Reagents LLC
- IgE CH3 peptide vaccine2 Feb 2016US 9,249,233 B2Pfizer Vaccines LLC
- Method of altering the binding specificity of plasma proteins by oxidation-reduction27 Oct 2015US 9,169,317 B2Redox-Reactive Reagents LLC
- Methods for treating chronic obstructive pulmonary disease7 Apr 2015US 8,999,339 B2
- C(epsilon)mX peptides for inducing immune responses to human mIgE on B lymphocytes10 Mar 2015US 8,974,794 B2Academia Sinica
- Systems and methods for improved in vivo analyte sensor function22 May 2025US 2025/0160698 A1Abbott Diabetes Care Inc.
- Systems and Methods for Improved In Vivo Analyte Sensor Function2 Jul 2020US 2020/0205706 A1Abbott Diabetes Care Inc.
- Method for altering the binding specificity of plasma proteins by oxidation18 Feb 2016US 2016/0046695 A1Redox-Reactive Reagents LLC
- Methods for treating chronic obstructive pulmonary disease27 Aug 2015US 2015/0239989 A1
- Reducing the immunogenicity of fusion proteins21 May 2015US 2015/0141626 A1Merck Patent GmbH
Most cited
By later US patents
- Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity737US 4,554,101 ANew York Blood Center, Inc. · 1985
- Human antibodies that bind human TNF.alpha.451US 6,090,382 ABASF SE · 2000
- Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor301US 5,605,690 AImmunex Corporation · 1997
- Receptor specific transepithelial transport of therapeutics240US 6,485,726 B1Brandeis University · 2002
- Human antibodies that bind human TNFa212US 6,509,015 B1BASF SE · 2003